Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
June 13, 2019
InflaRx Treats First Patient in Phase IIa Clinical Trial with Lead Candidate IFX-1 in Pyoderma Gangraenosum
JENA, Germany, June 13, 2019 (GLOBE NEWSWIRE) -- InflaRx N.V. (IFRX), an innovative biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, today announced ...
June 13, 2019
Inventiva announces the creation of its Scientific Advisory Board
Daix (France), June 13, 2019 – Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas ...
June 13, 2019
Zealand Pharma announces amendments to its Articles of Association following the granting of warrants
Copenhagen, June 13, 2019 – Zealand Pharma A/S (“Zealand”) (ZEAL) (CVR-no. 20 04 50 78), announces that its Articles of Association have been amended to reflect ...
June 11, 2019
OSE Immunotherapeutics Receives U.S. Patent Notice of Allowance for Use of Tedopi® to Treat Brain Metastasis
NANTES, France, June 11, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announced that the United States Patent and Trademark Office (USPTO) ...
June 11, 2019
CytoSorbents to Present at the Three Part Advisors 2019 East Coast IDEAS Investor Conference
MONMOUTH JUNCTION, N.J., June 11, 2019 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill ...
June 11, 2019
CymaBay Therapeutics Reports Topline 12-Week Data from an Ongoing Phase 2b Study of Seladelpar in Patients with Nonalcoholic Steatohepatitis
NEWARK, Calif., June 11, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY) today announced 12-week topline results from an ongoing 52-week Phase 2b dose-ranging, paired ...
June 11, 2019
MediWound Appoints Mr. Boaz Gur-Lavie as Chief Financial Officer
YAVNE, Israel, June 11, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
June 11, 2019
OncoCyte to be Added to the Russell 2000®, 3000® and Microcap Indexes
ALAMEDA, Calif., June 11, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung ...
June 11, 2019
Inventiva Announces End of Patient Recruitment for its Phase IIa Trial in the Treatment of MPS VI
Daix (France), June 11, 2019 – Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas ...
June 11, 2019
Valneva to Present Lyme Disease and Chikungunya Vaccine Updates at R&D Investor Day in New York City on July 9th
Saint Herblain (France), June 11, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major ...
June 11, 2019
STRATA Skin Sciences to Present at Upcoming Investor Conferences
HORSHAM, Pa., June 11, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences (SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery ...
June 10, 2019
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
TEL-AVIV, Israel and RALEIGH, N.C., June 10, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a ...
June 10, 2019
Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs
PALO ALTO, Calif., June 10, 2019 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of therapies for rare and ultra-rare diseases, today ...
June 10, 2019
Altimmune Announces Successful Pre-IND Meeting with FDA
GAITHERSBURG, Md., June 10, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced that it successfully completed a pre-IND (Investigational New Drug) ...
June 10, 2019
PolarityTE Announces Final Clinical Data from Pilot Study Showing Closure of Diabetic Foot Ulcers Using SkinTE
SALT LAKE CITY, June 10, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today the final ...
June 10, 2019
CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10
BERKELEY HEIGHTS, N.J., June 10, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...
June 10, 2019
Edap Tms: EDAP Announces Positive Outcome from CPT Panel for HIFU Reimbursement in the U.S.
LYON, France, June 10, 2019 -- EDAP TMS SA (EDAP) (“the Company”), the global leader in therapeutic ultrasound, today announced that the American Medical Association’s ...
June 10, 2019
Novus Therapeutics to Present OP0201 Data at the 20th International Symposium on Recent Advances in Otitis Media
Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced ...
June 10, 2019
CohBar poster available on preclinical results showing efficacy of a new family of mitochondria based therapeutics in a type 2 diabetes model as presented at the American Diabetes Association 79th Scientific Sessions
MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (CWBR), a clinical stage biotechnology company focused on developing mitochondria based therapeutics to treat ...
June 10, 2019
electroCore Announces Frank R. Amato to Step Down as Chief Executive Officer
BASKING RIDGE, N.J., June 10, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a commercial-stage bioelectronic medicine company, today announced that Frank R. Amato will be ...
Page 11 of 158